FYUST is the only private institution among the 14 newly-approved tertiary colleges in China, including eight others that also focus on science and engineering. Beijing is striving to close its ...

Sign up for the Marketplace newsletter to get the day’s biggest business stories, our economic analysis, and explainers to help you live smarter, straight to your ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...

“BLS has observed data quality problems because of ongoing issues with the modernization of Colorado’s unemployment insurance system. As a result, BLS is temporarily suspending publication of ...

make sure learning objectives are met, provide coaching skills, evaluate skills and performance, and follow AHA policies. This course covers the core content and the discipline-specific content ...

It’s become my “in case of emergency” product. Tamim is a beauty writer at InStyle, with nearly a decade of experience writing about beauty, fashion, wellness, and music. When people find ...

The deal does not include a provision to raise the debt limit. After days of heated negotiations on Capitol Hill and eleventh-hour interference from President-elect Donald Trump and his ally Elon ...

An estimated $450-million order will bring five new Airbus mid-range aircraft to the flag carrier as it pursues a fleet-renewal program. Air Canada is buying for five more A220-300 aircraft following ...

Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the first prescription drug to help alleviate moderate ...

Dec 17 (Reuters) - (This Dec. 17 story has been corrected to say that the EU regulator reversed its July decision in November to recommend approval for Biogen's drug, Leqembi, in paragraph 8 ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release ...